Clinical usefulness of serum free light chains measurement in patients with multiple myeloma: comparative analysis of two different tests

by Tadeusz Kubicki, Dominik Dytfeld, Aleksandra Baszczuk, Ewa Wysocka, Mieczysław Komarnicki, Krzysztof Lewandowski
Published 2017-01-01

Measurable residual disease assessed by mass spectrometry in peripheral blood in multiple myeloma in a phase II trial of carfilzomib, lenalidomide, dexamethasone and autologous ste...

by Benjamin A. Derman, Andrew T. Stefka, Ken Jiang, Amanda McIver, Tadeusz Kubicki, Jagoda K. Jasielec, Andrzej J. Jakubowiak
Published 2021-02-01